In June 1981, news of a mysterious disease first began making headlines out of San Francisco, Los Angeles and New York. People who were impacted developed unusual infections and grew sick as their ...

Yeztugo, a twice yearly injection, offers a promising advancement in HIV prevention, but high costs and insurance uncertainties may limit its accessibility.

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers successfully suppressed the virus in mice and discovered a way to kill infected cells ...

Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...

Declining investment in global health surveillance, research, and scientific innovation are happening as the need for vigilance has never been greater, writes Robert C. Gallo.

Three decades after Rae Lewis-Thornton became the face of HIV, the virus is still a major threat to Black women. She and experts explore why.

On Monday, the Alabama Department of Public Health observed Zero HIV Stigma Day. Zero HIV Stigma Day is a global grassroots ...

Since 1995, National HIV Testing Day has raised awareness and confronted stereotypes about HIV. Learn about HIV testing options and prevention methods.

A University of Utah doctor’s research led to a major HIV drug. He worries federal cuts will stop people from getting it. Wesley Sundquist’s discoveries have earned awards, but the biochemist ...

WASHINGTON (AP) -- The U.S. has approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions -- although it's unclear how ...

The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.